Epileptic seizures in AD patients

NeuroMolecular Medicine

Volumn 12, Issue 1, 2010, Pages 71-77

  Larner, A J ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Alzheimer's disease; Epilepsy; Presenilin 1; Seizures

Indexed keywords

AMYLOID BETA PROTEIN; ANTICONVULSIVE AGENT; COLLAPSIN RESPONSE MEDIATOR PROTEIN 2; ETIRACETAM; HARKOSERIDE; LAMOTRIGINE; PRESENILIN 1; VALPROIC ACID; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; BRAIN BLOOD VESSEL; BRAIN NERVE CELL; COMPLEX PARTIAL SEIZURE; CYTOSKELETON; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DRUG PROTEIN BINDING; DRUG TOLERABILITY; DRUG WITHDRAWAL; FOCAL EPILEPSY; GENE MUTATION; GRAND MAL SEIZURE; HUMAN; NERVE DEGENERATION; NEUROTRANSMISSION; PATHOPHYSIOLOGY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; RISK; SEIZURE; THERAPY; ANIMAL; CLINICAL TRIAL; COMORBIDITY; DISEASE MODEL; EPILEPSY; GENETICS; METABOLISM; MUTATION;

ANIMALIA;

ALZHEIMER DISEASE; ANIMALS; CLINICAL TRIALS AS TOPIC; COMORBIDITY; DISEASE MODELS, ANIMAL; EPILEPSY; HUMANS; MUTATION; PRESENILIN-1;

EID: 77952510145     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12017-009-8076-z     Document Type: Review

References (72)

1. Aldenkamp, A. P., & Bodde, N. (2005). Behaviour, cognition and epilepsy. Acta Neurológica Scandinavica. Supplementum, 182, 19-25.
2. Alzheimer, A. (1907). Über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift fur Psychiatrie und psychischgerichtliche Medicin, 64, 146-148.
3. Amatniek, J. C., Hauser, W. A., DelCastillo-Castaneda, C., Jacobs, D. M., Marder, K., Bell, K., et al. (2006). Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia, 47, 867-872. (Pubitemid 44030181)
4. Arimura, N., Ménager, C., Kawano, Y., et al. (2005). Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Molecular and Cellular Biology, 25, 9973-9984. (Pubitemid 41572744)
5. Armon, C., Peterson, G. W., & Liwnicz, B. H. (2000). Alzheimer's disease underlies some cases of complex partial status epilepticus. Journal of Clinical Neurophysiology, 17, 511-518.
6. Babic, T., & Zurak, N. (1999). Convulsions induced by donepezil. Journal of Neurology, Neurosurgery and Psychiatry, 66, 410.
7. Beicastro, V., Costa, C., Galletti, F., Pisani, F., Calabresi, P., & Parnetti, L. (2007). Levetiracetam monotherapy in Alzheimer patients with late-onset seizures: A prospective observational study. European Journal of Neurology, 14, 1176-1178. (Pubitemid 47459735)
8. Belyaev, N. D., Nalivaeva, N. N., Makova, N. Z., & Turner, A. J. (2009). Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: Implications for Alzheimer disease. EMBO Reports, 10, 94-100.
9. Beyreuther, B. K., Freitag, J., Heers, C., Krebsfänger, N., Scharfenecker, U., & Stöhr, T. (2007). Lacosamide: A review of preclinical properties. CNS Drug Reviews, 13, 21-42.
10. Borghani Haghighi, A., & Sabayan, B. (2008). Can prolonged administration of valproic acid put patients with epilepsy at higher risk for development of Alzheimer's disease? Epilepsy & Behavior, 12, 206-207.
11. Chandra, V., Bharucha, N. E., & Schoenberg, B. S. (1986). Conditions associated with Alzheimer's disease at death: Casecontrol studies. Neurology, 36, 209-211. (Pubitemid 16124210)
12. Cirrito, J. R., Kang, J. E., Lee, J., et al. (2008). Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo. Neuron, 58, 42-51. (Pubitemid 351467029)
13. Cirrito, J. R., Yamada, K A., Finn, M. B., et al. (2005). Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron, 48, 913-922.
14. Clark, C., Heyman, A., Earl, N., Utley, C., & Haynes, C. (1991). Myoclonus in Alzheimer's disease. In K Iqbal, D. R. C. McLachlan, B. Winblad, & H. M. Wisniewski (Eds.), Alzheimer's disease: Basic mechanisms, diagnosis and therapeutic strategies (pp. 35-40). Chichester: Wiley.
15. Crespei, A., Gonzalez, V., Coubes, P., & Gelisse, P. (2007). Senile myoclonic epilepsy of Genton: Two cases in Down syndrome with dementia and late onset epilepsy. Epilepsy Research, 77, 165-168. (Pubitemid 350137690)
16. De Simone, R., Daguin, G., & Genton, P. (2006). Senile myoclonic epilepsy in Down syndrome: A video and EEG presentation of two cases. Epileptic Disorders, 8, 223-227. (Pubitemid 44546257)
17. Dhikav, V., & Anand, K (2007). Hippocampal atrophy may be a predictor of seizures in Alzheimer's disease. Medical Hypotheses, 69, 234-235. (Pubitemid 46705475)
18. Edwards-Lee, T., Ringman, J. M., Chung, J., et al. (2005). An African-American family with early-onset Alzheimer disease and an APP (T714I) mutation. Neurology, 64, 377-379.
19. Forsgren, L., Bucht, G., Eriksson, S., & Bergmark, L. (1996). Incidence and clinical characterization of unprovoked seizures in adults: A prospective population-based study. Epilepsia, 37, 224-229. (Pubitemid 26071822)
20. Förstl, H., Burns, A., Levy, R., Cairns, N., Luthert, P., & Lantos, P. (1992). Neurologic signs in Alzheimer's disease. Results of a prospective clinical and neuropathologic study. Archives of Neurology, 49, 1038-1042.
21. Genton, P., & Paglia, G. (1994). Epilepsie myoclonique senile? Myoclonies d'apparition tardive dans 1e syndrome de Down. Epilepsies, 1, 5-11. (Pubitemid 24120102)
22. Good, P. F., Alapat, D., Hsu, A., et al. (2004). A role for semaphorin 3 A signalling in the degeneration of hippocampal neurons during Alzheimer's disease. Journal of Neurochemistry, 91, 716-736. (Pubitemid 39431165)
23. Griffith, H. R., Martin, R. C., Bambara, J. K., Marson, D. C., & Faught, E. (2006). Older adults with epilepsy demonstrate cognitive impairments compared with patients with amnestic mild cognitive impairment. Epilepsy & Behavior, 8, 161-168.
24. Guan, J. S., Haggarty, S. J., Giacometti, E., et al. (2009). HDAC2 negatively regulates memory formation and synaptic plasticity. Nature, 459, 55-60.
25. Hauser, W. A., Morris, M. L., Heston, L. L., & Anderson, V. E. (1986). Seizures and myoclonus in patients with Alzheimer's disease. Neurology, 36, 1226-1230. (Pubitemid 16047002)
26. Herrmann, N., Lanctot, K. L., Rothenburg, L. S., & Eryavec, G. (2007). A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 23, 116-119. (Pubitemid 46105702)
27. Hesdorffer, D. C., Häuser, W. A., Annegers, J. F., Kokmen, E., & Rocca, W. A. (1996). Dementia and adult-onset unprovoked seizures. Neurology, 46, 727-730.
28. HØgh, P., Smith, S. J., Scahill, R. I., Chan, D., Harvey, R. J., Fox, N. C., et al. (2002). Epilepsy presenting as AD: Neuroimaging, electroclinical features, and response to treatment. Neurology, 58, 298-301. (Pubitemid 34084225)
29. Hommet, C., Hureaux, R., Barré, J., Constans, T., & Berrut, G. (2007). Epileptic seizures in clinically diagnosed Alzheimer's disease: Report from a geriatric medicine population. Aging Clinical and Experimental Research, 19, 430-431. (Pubitemid 350285304)
30. Krishnan K., & Larner A. J. (2009). Concurrent onset of transient epileptic amnesia and Alzheimer's disease. European Journal of Neurology 16 (in press).
31. Larner, A. J. (1995a). The cortical neuritic dystrophy of Alzheimer's disease: Nature, significance, and possible pathogenesis. Dementia, 6, 218-224.
32. Larner, A. J. (1995b). Axonal sprouting and synaptogenesis in temporal lobe epilepsy: Possible pathogenetic and therapeutic roles of neurite growth inhibitory factors. Seizure, 4, 249-258.
33. Larner, A. J. (2007). Down syndrome in the neurology clinic: Too much? Too little? Too late? Downs Syndrome, Research and Practice, 12, 69-71.
34. Larner, A. J. (2008). Alzhemer's disease. In S. F. Cappa, J. Abutalebi, J. F. Démonet, P. C. Fletcher, & P. Garrard (Eds.), Cognitive neurology. A clinical textbook (pp. 199-227). Oxford: Oxford University Press.
35. Larner, A. J., & Doran, M. (2006). Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. Journal of Neurology, 253, 139-158.
36. Larner A. J., & Doran M. (2009a). Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: An update. Journal of Alzheimer's Disease 14 (in press).
37. Larner, A. J., & Doran, M. (2009b). Clinical heterogeneity associated with tau gene mutations. European Neurological Review, 3(2), 31-32.
38. Larner, A. J., & Keynes, R. J. (2006). Neuroinhibitory molecules in Alzheimer's disease. Journal of Alzheimer's Disease, 10, 75-80.
39. Leonard, A. S., & McNamara, J. O. (2007). Does epileptiform activity contribute to cognitive impairment in Alzheimer's disease? Neuron, 55, 677-678. (Pubitemid 47321090)
40. Li, L. M., O'Donoghue, M. F., & Sander, J. W. (1995). Myoclonic epilepsy of late onset in trisomy 21. Arquivos de Neuropsiquiatria, 53, 792-794.
41. Loring, D. W., Marino, S., & Meador, K. J. (2007). Neuropsychological and behavioural effects of antiepilepsy drugs. Neuropsychology Review, 17, 413-425. (Pubitemid 350231552)
42. Lozsadi, D. A., Chadwick, D. W., & Larner, A. J. (2008). Late-onset temporal lobe epilepsy with unilateral mesial temporal sclerosis and cognitive decline: A diagnostic dilemma. Seizure, 17, 473-416.
43. Lozsadi, D. A., & Larner, A. J. (2006). Prevalence and causes of seizures at the time of diagnosis of probable Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 22, 121-124.
44. McAreavey, M. J., Ballinger, B. R., & Fenton, G. W. (1992). Epileptic seizures in elderly patients with dementia. Epilepsia, 33, 657-660.
45. McKhann, G., Drachman, D., Folstein, M., et al. (1984). Clinical diagnosis of Alzheimer's disease. Report of the NINCDSADRDA work group under the auspices of the Department of Health and Human Service Task forces on Alzheimer's disease. Neurology, 34, 939-944. (Pubitemid 14076461)
46. Melanson, M., Nalbantoglu, J., Berkovic, S., Melmed, C., Andermann, E., Roberts, L. J., et al. (1997). Progressive myoclonus epilepsy in young adults with neuropathologic features of Alzheimer's disease. Neurology, 49, 1732-1733. (Pubitemid 28015153)
47. Mendez, M. F., Catanzaro, P., Doss, R. C., Arguello, R., & Frey, W. H. J. (1994). Seizures in Alzheimer's disease: Clinicopathologic study. Journal of Geriatric Psychiatry and Neurology, 7, 230-233. (Pubitemid 24330514)
48. Mendez, M. F., & Lim, G. T. H. (2003). Seizures in elderly patients with dementia: Epidemiology and management. Drugs and Aging, 20, 791-803. (Pubitemid 37159597)
49. Menendez, M. (2005). Down syndrome, Alzheimer's disease and seizures. Brain and Development, 27, 246-252. (Pubitemid 40602865)
50. Minkeviciene, R., Rheims, S., Dobszay, M. B., et al. (2009). Amyloid β-induced neuronal hyperexcitability triggers progressive epilepsy. Journal of Neuroscience, 29, 3453-3462.
51. Moehlmann, T., Winkler, E., Xia, X., et al. (2002). Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ342 production. Proceedings of the National Academy of Sciences of the United States of America, 99, 8025-8030. (Pubitemid 34650999)
52. Möller, J. C., Hamer, H. M., Oertel, W. H., & Rosenow, F. (2001). Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure, 10, 303-306.
53. Mrak, R. E., & Griffin, W. S. (2004). Trisomy 21 and the brain. Journal of Neuropathology and Experimental Neurology, 63, 679-685.
54. MRC CFAS. (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study. Lancet, 357, 169-175.
55. Neary, D., Snowden, J. S., Bowen, D. M., et al. (1986). Cerebral biopsy in the investigation of presenile dementia due to cerebral atrophy. Journal of Neurology, Neurosurgery and Psychiatry, 49, 157-162. (Pubitemid 16155689)
56. Palop, J. J., Chin, J., Roberson, E. D., et al. (2007). Aberrant excitatory neuronal activity and compensatory remodelling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron, 55, 697-711. (Pubitemid 47321079)
57. Puri, B. K., Ho, K. W., & Singh, I. (2001). Age of seizure onset in adults with Down's syndrome. International Journal of Clinical Practice, 55, 442-444.
58. Qing, H., He, G., Ly, P. T., et al. (2008). Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models. Journal of Experimental Medicine, 205, 2781-2789.
59. Rabinowicz, A. L., Starkstein, S. E., Leiguarda, R. C., & Coleman, A. E. (2000). Transient epileptic amnesia in dementia: A treatable unrecognized cause of episodic amnestic wandering. Alzheimer Disease and Associated Disorders, 14, 231-233.
60. Rao, S. C., Dove, G., Cascino, G. D., & Petersen, R. C. (2009). Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome. Epilepsy & Behavior, 14, 118120.
61. Risse, S. C., Lampe, T. H., Bird, T. D., et al. (1990). Myoclonus, seizures and paratonia in Alzheimer's disease. Alzheimer Disease and Associated Disorders, 4, 217-225.
62. Romanelli, M. F., Morris, J. C., Ashkin, K., & Coben, L. A. (1990). Advanced Alzheimer's disease is a risk factor for late-onset seizures. Archives of Neurology, 47, 847-850. (Pubitemid 20251713)
63. Scarmeas, N., Honig, L., Choi, H., et al. (2005). Seizures in Alzheimer's disease: Frequency and predictors. European Journal of Neurology, 72(Suppl 2), 59. abstract P1090.
64. Seltzer, B., & Sherwin, L. (1983). A comparison of clinical features in early- and late-onset primary degenerative dementia. Archives of Neurology, 40, 143-146. (Pubitemid 13139113)
65. Sinforiani, E., Manni, R., Bernasconi, L., Banchieri, L. M., & Zucchella, C. (2003). Memory disturbances and temporal lobe epilepsy simulating Alzheimer's disease: A case report. Functional Neurology, 18, 39-41.
66. Sulkava, R. (1982). Alzheimer's disease and senile dementia of the Alzheimer type: A comparative study. Acta Neurologica Scandinavica, 65, 636-650. (Pubitemid 12085603)
67. Tatum, W. O., Ross, J., & Cole, A. J. (1998). Epileptic pseudodementia. Neurology, 50, 1472-1475.
68. Tekin, S., Aykut-Bingol, C., Tanridag, T., & Aktan, S. (1998). Antiglutamatergic therapy in Alzheimer's disease- Effects of lamotrigine. Short communication. Journal of Neural Transmission, 105, 295-303.
69. Tombini, M., Koch, G., Placidi, F., Sancesario, G., Marciani, M. G., & Bernardi, G. (2005). Temporal lobe epileptic activity mimicking dementia: A case report. European Journal of Neurology, 12, 805-806. (Pubitemid 41495138)
70. Velez-Pardo, C., Arellano, J. I., Cardona-Gomez, P., et al. (2004). CAl hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy. Epilepsia, 45, 751-756. (Pubitemid 38890972)
71. Volicer, L., Smith, S., & Volicer, B. J. (1995). Effect of seizures on progression of dementia of the Alzheimer type. Dementia, 6, 258-263.
72. Yoshida, H., Watanabe, A., & Ihiara, Y. (1998). Collapsin response mediator protein-2 is associated with neurofibrillary tangles in Alzheimer's disease. Journal of Biological Chemistry, 273, 9761-9768. (Pubitemid 28183069)